Literature DB >> 21035176

Mast cell activation syndrome: Proposed diagnostic criteria.

Cem Akin1, Peter Valent, Dean D Metcalfe.   

Abstract

The term mast cell activation syndrome (MCAS) is finding increasing use as a diagnosis for subjects who present with signs and symptoms involving the dermis, gastrointestinal track, and cardiovascular system frequently accompanied by neurologic complaints. Such patients often have undergone multiple extensive medical evaluations by different physicians in varied disciplines without a definitive medical diagnosis until the diagnosis of MCAS is applied. However, MCAS as a distinct clinical entity has not been generally accepted, nor do there exist definitive criteria for diagnosis. Based on current understanding of this disease "syndrome" and on what we do know about mast cell activation and resulting pathology, we will explore and propose criteria for its diagnosis. The proposed criteria will be discussed in the context of other disorders involving mast cells or with similar presentations and as a basis for further scientific study and validation. Published by Mosby, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21035176      PMCID: PMC3753019          DOI: 10.1016/j.jaci.2010.08.035

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  21 in total

1.  Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis.

Authors:  Cem Akin; Linda M Scott; Can N Kocabas; Nataliya Kushnir-Sukhov; Erica Brittain; Pierre Noel; Dean D Metcalfe
Journal:  Blood       Date:  2007-07-16       Impact factor: 22.113

Review 2.  Mast cells and mastocytosis.

Authors:  Dean D Metcalfe
Journal:  Blood       Date:  2008-08-15       Impact factor: 22.113

3.  Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: Monoclonal mast cell activation syndrome.

Authors:  Karoline Sonneck; Stefan Florian; Leonhard Müllauer; Friedrich Wimazal; Manuela Födinger; Wolfgang R Sperr; Peter Valent
Journal:  Int Arch Allergy Immunol       Date:  2006-10-20       Impact factor: 2.749

4.  Kit- and Fc epsilonRI-induced differential phosphorylation of the transmembrane adaptor molecule NTAL/LAB/LAT2 allows flexibility in its scaffolding function in mast cells.

Authors:  Shoko Iwaki; Jiri Spicka; Christine Tkaczyk; Bettina M Jensen; Yasuko Furumoto; Nicolas Charles; Martina Kovarova; Juan Rivera; Vaclav Horejsi; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  Cell Signal       Date:  2007-10-16       Impact factor: 4.315

5.  Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder.

Authors:  Gerhard J Molderings; Ulrich W Kolck; Christian Scheurlen; Michael Brüss; Jürgen Homann; Ivar Von Kügelgen
Journal:  Scand J Gastroenterol       Date:  2007-09       Impact factor: 2.423

6.  Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.

Authors:  H Nagata; A S Worobec; C K Oh; B A Chowdhury; S Tannenbaum; Y Suzuki; D D Metcalfe
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

Review 7.  The mast cell and allergic diseases: role in pathogenesis and implications for therapy.

Authors:  J M Brown; T M Wilson; D D Metcalfe
Journal:  Clin Exp Allergy       Date:  2007-11-21       Impact factor: 5.018

8.  Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis.

Authors:  David González de Olano; Iván Alvarez-Twose; María I Esteban-López; Laura Sánchez-Muñoz; María D Alonso Díaz de Durana; Arantza Vega; Andres García-Montero; Eloina González-Mancebo; Teresa Belver; María D Herrero-Gil; Montserrat Fernández-Rivas; Alberto Orfao; Belén de la Hoz; Mariana C Castells; Luis Escribano
Journal:  J Allergy Clin Immunol       Date:  2008-01-04       Impact factor: 10.793

Review 9.  Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias.

Authors:  J Gotlib; J Cools
Journal:  Leukemia       Date:  2008-10-09       Impact factor: 11.528

10.  Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients.

Authors:  K Brockow; C Jofer; H Behrendt; J Ring
Journal:  Allergy       Date:  2008-02       Impact factor: 13.146

View more
  67 in total

1.  Characterization of Mast Cell Activation Syndrome.

Authors:  Lawrence B Afrin; Sally Self; Jeremiah Menk; John Lazarchick
Journal:  Am J Med Sci       Date:  2016-12-16       Impact factor: 2.378

2.  Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal.

Authors:  Peter Valent; Cem Akin; Michel Arock; Knut Brockow; Joseph H Butterfield; Melody C Carter; Mariana Castells; Luis Escribano; Karin Hartmann; Philip Lieberman; Boguslaw Nedoszytko; Alberto Orfao; Lawrence B Schwartz; Karl Sotlar; Wolfgang R Sperr; Massimo Triggiani; Rudolf Valenta; Hans-Peter Horny; Dean D Metcalfe
Journal:  Int Arch Allergy Immunol       Date:  2011-10-27       Impact factor: 2.749

3.  Fecal Concentrations of N-methylhistamine in Common Marmosets (Callithrix jacchus).

Authors:  Joseph Cyrus Parambeth; Franklin R López; Rosana Lopez; Sarah B Keyser; Jonathan A Lidbury; Jan S Suchodolski; Jörg M Steiner
Journal:  Comp Med       Date:  2019-02-25       Impact factor: 0.982

Review 4.  Flushing Disorders Associated with Gastrointestinal Symptoms: Part 1, Neuroendocrine Tumors, Mast Cell Disorders and Hyperbasophila.

Authors:  Vaibhav Rastogi; Devina Singh; Joseph J Mazza; Dipendra Parajuli; Steven H Yale
Journal:  Clin Med Res       Date:  2018-04-12

Review 5.  Mast Cell Activation Syndrome.

Authors:  Marianne Frieri
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

6.  Mutational profiling in the peripheral blood leukocytes of patients with systemic mast cell activation syndrome using next-generation sequencing.

Authors:  Janine Altmüller; Britta Haenisch; Amit Kawalia; Markus Menzen; Markus M Nöthen; Heide Fier; Gerhard J Molderings
Journal:  Immunogenetics       Date:  2017-04-06       Impact factor: 2.846

7.  Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications.

Authors:  Maria Jara-Acevedo; Cristina Teodosio; Laura Sanchez-Muñoz; Ivan Álvarez-Twose; Andrea Mayado; Carolina Caldas; Almudena Matito; José M Morgado; Javier I Muñoz-González; Luis Escribano; Andrés C Garcia-Montero; Alberto Orfao
Journal:  Mod Pathol       Date:  2015-06-12       Impact factor: 7.842

Review 8.  Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?

Authors:  Theoharis C Theoharides; Irene Tsilioni; Huali Ren
Journal:  Expert Rev Clin Immunol       Date:  2019-04-22       Impact factor: 4.473

Review 9.  Mast cell activation syndrome: a review.

Authors:  Marianne Frieri; Reenal Patel; Jocelyn Celestin
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

Review 10.  Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics.

Authors:  Britta Haenisch; Markus M Nöthen; Gerhard J Molderings
Journal:  Immunology       Date:  2012-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.